Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
Cheezheng Tibetan Medicine was approved to IPO on the...
California's stem cell institute has signed an MOU with...
PPD, Inc. will acquire BioDuro, a preclinical CRO, as a...
BioMarin Pharma will pay up to $96 million to acquire...
Tigermed Consulting formed a China clinical CRO alliance...
Tongjitang Chinese Medicines Co. is...
CCB’s $400 million China health care fund may...
The BioBay Investor Forum selected BeiGene LLC and Suzhou...
BeiGene of Beijing out-licensed the ex-China rights for a...
CBT 200 Drops 5.7%. More details...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
